CTMX Market Cap & Key Metrics
CytomX Therapeutics, Inc.
$1.96
-$0.02(-1.26%)
33
Overall
45
Value
10
Tech
44
Quality
Market Cap
$426.20M
Volume
14.86M
52W Range
$2.11 - $8.21
Target Price
$12.25
CTMX market cap is $426.20M. This page lists CytomX Therapeutics, Inc.'s P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
CTMX Key Metrics
- Market cap
- $426.20M
- EPS estimate, current year
- $-0.40
- EPS growth, 3-year
- +53.69%
- Value score
- 45
- Quality score
- 44
- Technical score
- 10
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $76.20M | $138.10M | $101.21M | $53.16M | $37.31M |
| EBITDA | -$20.99M | $32.24M | $5.50M | -$98.89M | -$113.34M |
| EPS | $-0.15 | $0.38 | $-0.01 | $-1.51 | $-1.30 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CTMX | $1.96 | -1.3% | 14.86M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get CytomX Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW